Abstract
Genetically modified mice have become standard tools in neuroscience research. Our understanding of the basal ganglia in particular has been greatly assisted by BAC mutants with selective transgene expression in striatal neurons forming the direct or indirect pathways. However, for more sophisticated behavioral tasks and larger intracranial implants, rat models are preferred. Furthermore, BAC lines can show variable expression patterns depending upon genomic insertion site. We therefore used CRISPR/Cas9 to generate two novel knock-in rat lines specifically encoding Cre recombinase immediately after the dopamine D1 receptor (Drd1a) or adenosine 2a receptor (Adora2a) loci. Here, we validate these lines using in situ hybridization and viral vector mediated transfection to demonstrate selective, functional Cre expression in the striatal direct and indirect pathways, respectively. We used whole-genome sequencing to confirm the lack of off-target effects and established that both rat lines have normal locomotor activity and learning in simple instrumental and Pavlovian tasks. We expect these new D1-Cre and A2a-Cre rat lines will be widely used to study both normal brain functions and neurological and psychiatric pathophysiology.
Significance Statement
This work presents the generation and validation of two novel knock-in rat lines. We demonstrate that the Cre transgene was correctly inserted at the intended genomic locations only and that the rats show normal behavior in a range of simple tests. We validate that Cre is expressed with high specificity and consistency and produces functional Cre-dependent protein expression in vivo. Among other applications, these lines will be valuable tools for selective investigations of the striatal direct and indirect pathways.
Introduction
Dopamine and adenosine are important chemical messengers in the brain, vasculature, and elsewhere in the body. Within the brain, one key site of action is the striatum (including nucleus accumbens), a critical component of basal ganglia circuitry involved in movement, motivation, and reinforcement-driven learning (Denny‐Brown and Yanagisawa, 1976; Marsden, 1982; Gerfen and Surmeier, 2011; Berke, 2018). Most (90–95%) striatal neurons are GABAergic medium spiny neurons (MSNs) with two distinct subclasses (Gerfen and Surmeier, 2011). “Direct pathway” neurons (dMSNs) express dopamine-D1 receptors and project primarily to the substantia nigra pars reticulata/globus pallidus pars interna (SNr/GPi), whereas “indirect pathway” neurons (iMSNs) express both dopamine-D2 receptors and adenosine-A2a receptors, and project primarily to the globus pallidus pars externa (GPe). Although our understanding of their distinct functions is incomplete, dMSNs and iMSNs have complementary roles promoting and discouraging motivated behaviors, respectively (Collins and Frank, 2014).
The investigation of dMSNs and iMSNs has been transformed by transgenic mice. Random genomic insertion of BACs (bacterial artificial chromosomes) encoding dopamine receptor promoters driving fluorescent protein expression confirmed the near-total segregation of striatal D1 and D2 receptors (Shuen et al., 2008; Matamales et al., 2009) and enabled identification of dMSNs/iMSNs in brain slices (Day et al., 2006). BAC lines in which dopamine receptor promoters drive Cre recombinase expression (D1-Cre, D2-Cre, etc.) have allowed in vivo identification and manipulation of neuronal subpopulations in striatum (Kravitz et al., 2010, 2012; Cui et al., 2013; Barbera et al., 2016) and cortex (Kim et al., 2017). iMSNs targeting is further improved using an A2a promoter, rather than D2, because A2a receptors are selectively expressed on iMSNs while D2 receptors are also expressed on other striatal cells and synapses (Alcantara et al., 2003).
However, for many experiments, rats are more suitable than mice. Their larger size means they can bear complex intracranial implants without loss of mobility. Furthermore, rats can learn more sophisticated behavioral tasks, including those investigating reinforcement learning (Hamid et al., 2016) and behavioral inhibition (Schmidt et al., 2013). The advent of CRISPR/Cas9 methods has facilitated the generation of knock-in rat lines (Mali et al., 2013; Jung et al., 2016), and knock-ins are more likely to have faithful expression patterns compared to BACs for which (for example) different D1-Cre lines show markedly different expression (Heintz, 2004).
Here, we describe the generation of transgenic D1-Cre and A2a-Cre rat lines using CRISPR/Cas9. We then demonstrate the specificity of iCre mRNA expression in the intended cells, in both dorsal striatum (DS) and nucleus accumbens. Next, we confirm Cre-dependent expression to demonstrate that Cre is functional and appropriately confined to the direct or indirect pathways. Finally, we demonstrate normal locomotor activity, learning and motivation in simple behavioral tasks.
Materials and Methods
All animal procedures were approved by the relevant Institutional Animal Care and Use Committees.
Genetic engineering
CRISPR/Cas9 (Mali et al., 2013) was used to generate genetically-modified rat strains. Two single guide RNA (sgRNA) targets and protospacer adjacent motifs (PAMs) were identified downstream of the rat Adora2a termination codon (Hsu et al., 2013). sgRNA targets were cloned into plasmid pX330 (Addgene #42230, a gift of Feng Zhang) as described (Ran et al., 2013). Guide targets were C30G1: CTAAGGGAAGAGAAACCCAA PAM: TGG, and C30G2: GGCTGGACCAATCTCACTAA PAM: GGG. Purified pX330 plasmids were co-electroporated into rat embryonic fibroblasts with a PGKpuro plasmid (McBurney et al., 1994). Genomic DNA was prepared after transient selection with puromycin (2 µg/ml). A 324-bp DNA fragment spanning the expected Cas9 cut sites was PCR-amplified with forward primer GGGATGTGGAGCTTCCTACC and reverse primer GCAGCCCTGACCTAACACAG. DNA sequencing of the amplicons showed that C30G1-treated, but not C30G2-treated, cells contained overlapping chromatogram peaks, indicative of multiple templates that differ because of non-homologous end-joining repair of CRISR/Cas9-induced chromosome breaks resulting in the presence of small deletions/insertions (indels). sgRNA C30G1 was chosen for rat zygote microinjection. A DNA donor was synthesized (BioBasic, cloned in pUC57) to introduce the following elements between codon 410 and the termination codon of Adora2a: a glycine-serine-serine linker with porcine teschovirus-1 self-cleaving peptide 2A (P2A; Kim et al., 2011) followed by iCre recombinase (Shimshek et al., 2002) with hemagglutinin tag YPYDVPDYA (Kolodziej and Young, 1991) and a termination codon with the bovine growth hormone polyadenylation sequence (Goodwin and Rottman, 1992). To mediate homologous recombination a 5’ arm of homology (1804 bp of genomic DNA 5’ to codon 410) and a 3’ arm of homology (1424 bp of genomic DNA downstream of the termination codon) were used. The 20-bp sequence of C30G1 was omitted from the 3’ arm of homology to prevent CRISPR/Cas9 cleavage of the chromosome after insertion of the DNA donor.
A similar approach was used for Drd1a. Two sgRNA were identified downstream of the Drd1a termination codon, C31G1: TTCCTTAACAGCAAGCCCAA PAM: GGG and C31G2: CTGAGGCCACGAGTTCCCTT PAM: GGG. A 293-bp DNA fragment spanning expected Cas9 cut sites was PCR-amplified with forward primer TGGAATAGCTAAGCCACTGGA and reverse primer CTCCCAAACTGA TTTCAGAGC. Both sgRNAs were found to be active after transfection in rat fibroblasts by T7 endonuclease 1 (T7E1) assays (Sakurai et al., 2014). Briefly, DNA amplicons were melted and re-annealed, then subjected to T7EI digestion. The presence of indels produced by non-homologous endjoining repair of Cas9-induced double strand breaks resulted in the presence of lower molecular weight DNA fragments for both sgRNA targets, and C31G1 was chosen for zygote microinjection. A DNA donor was synthesized (BioBasic, cloned in pUC57) to introduce the following elements between Drd1a codon 446 and the termination codon: a glycine-serine-serine linker with P2A followed by iCre recombinase with V5 peptide tag GKPIPNPLLGLDST (Yang et al., 2013) and a termination codon with the bovine growth hormone polyadenylation sequence. To mediate homologous recombination a 5’ arm of homology (1805 bp of genomic DNA 5’ of codon 446) and a 3’ arm (1801 bp of genomic DNA downstream of the termination codon) were used. The 20-bp sequence of C31G1 was omitted from the 3’ arm of homology to prevent cleavage of the chromosome after insertion.
Rat zygote microinjection was conducted as described (Filipiak and Saunders, 2006). sgRNA molecules from a PCR-amplified template were obtained by in vitro transcription (MAXIscript T7 Transcription kit followed by MEGAclear Transcription Clean-Up kit, Thermo Fisher Scientific). The template was produced from overlapping long primers (IDTDNA) that included one gene-specific sgRNA target and T7 promoter sequence that were annealed to a long primer containing the sgRNA scaffold sequence (Lin et al., 2014). Cas9 mRNA was obtained from Sigma-Aldrich. Circular DNA donor plasmids were purified with an endotoxin-free kit (QIAGEN).
Knock-in rats were produced by microinjection of a solution containing 5 ng/μl Cas9 mRNA, 2.5 ng/μl sgRNA, and 10 ng/μl of circular donor plasmid. Before rat zygote microinjection, fertilized mouse eggs were microinjected with the nucleic acid mixtures to ensure that the plasmid DNA mixtures did not cause zygote death or block development to the blastocyst stage. Rat zygotes for microinjection were obtained by mating superovulated Long–Evans female rats with Long–Evans male rats from an in-house breeding colony. A total of 353 rat zygotes were microinjected with A2a-Cre reagents, 289 survived and were transferred to pseudopregnant SD female rats (Strain 400, Charles River), resulting in 60 rat pups; 401 rat zygotes were microinjected with D1-Cre reagents, 347 survived and were transferred, resulting in 95 pups. Genomic DNA was purified from tail tip biopsies (QIAGEN DNeasy kit) to screen potential founders for correct insertion of iCre.
Colony management and genotyping
Lines were maintained by backcrossing with wild-type Long–Evans rats (Charles River or Harlan). Offspring were genotyped using real-time PCR (Transnetyx), using insertion-spanning primers (Table 2).
Genome sequencing was performed at the UCSF Institute for Human Genetics using blood samples (1 ml per rat) from 5th generation backcrossed rats. Libraries were prepared from fragmented DNA (Kapa Hyper Prep) and sequenced (Illumina NovaSeq 6000, S4 flow cell, paired-end mode, read lengths 150 bp). Sequencing reads were aligned to the rat genome (RGSC Rnor_6.0) using the Burrows-Wheeler Aligner (BWA-MEM). We used GATK HaplotypeCaller, Samtools, Bedtools, Pysam, and MATLAB for variant calling, subsequent analysis and visualization.
To determine the location of the inserted iCre cassette, we selected reads that did not align as a pair to the rat genome, which includes reads where only one mate or no mate of the pair aligned to the genome. These unaligned reads will include matches to the inserted iCre cassette sequence, which is not part of the reference genome. We searched for paired-end reads where one mate is aligned to the iCre cassette and then examined where in the genome the other mate is aligned.
To further verify the integrity of our lines we examined potential off-targets (D1-Cre: 197 sites and A2a-Cre: 557 sites) predicted by an in silico sgRNA off-target prediction algorithm (CRISPOR.net RSGC Rnor_6.0). CRISPR/Cas9-induced mutations in exons are of particular concern. Only two potential off-targets were predicted to be in exons in the D1-Cre line and none in the A2a-Cre line. After analyzing assembled genomic sequence data, we found the D1-Cre sequence contained a one base pair deletion at chr18:49935989 (Zfp608) and a single nucleotide variant (SNV) at ch1:258074844 (Cyp2c). On inspection, these changes were present in both the D1-Cre line and the A2a-Cre line, consistent with natural variations in the Long–Evans strain rather than off-target mutations from the D1-targeting sgRNA. Among the 195 predicted intronic off-targets for the D1-Cre strain located in introns, we observed 11 changes (eight contained SNVs and three contained indels). For the 557 predicted intronic off-target locations in the A2a-Cre strain, 48 locations showed changes (39 contained SNVs, six contained indels, and three contained both). Closer inspection of the indels revealed that 100% were present in both D1-Cre and A2a-Cre lines. This is again consistent with Long–Evans strain variation rather than off-target changes.
In situ hybridization
Frozen brains (n = 6, one male and two females from each line) were stored at –80°C (overnight, two weeks), then sectioned on a cryostat at 20 μm and mounted on glass slides. Sections were fixed in 4% PFA at 4°C for 15 min and dehydrated through 50%, 75%, 100% and fresh 100% EtOH at room temperature (RT) for 5 min each. Slides were dried completely for 5 min. A hydrophobic barrier (Advanced Cell Diagnostics) was drawn around each section. Slides were rinsed twice in 1× PBS (∼1–3 min) and incubated with Protease IV reagent (Advanced Cell Diagnostics) for 30 min at RT. Fluorescent probes (RNAScope, Advanced Cell Diagnostics, iCre catalog 312281, Drd1a catalog 317031-C2, and Adora2a catalog 450471-C3) were added (2 h, 40°C) followed by manufacturer-specified washing and amplification. DAPI was added to the slides before coverslipping (Prolong Gold, Thermo Fisher Scientific).
We used MIPAR software (https://www.mipar.us) to segment cell boundaries and fluorescent puncta using separate processing pipelines. To define nuclear boundaries, the DAPI channel of each image was first histogram-equalized to compensate for uneven illumination (512 × 512 pixel tiles) and convolved with a pixel-wise adaptive low-pass Wiener filter (5 × 5 pixel neighborhood size) to reduce noise. The image was then contrast-adjusted (saturating the top and bottom 1% of intensities). Bright objects were segmented using an adaptive threshold (pixel intensity >110% of mean in the surrounding 30-pixel window). Image erosion followed by dilation further reduced noise (five-pixel connectivity threshold, 10 iterations). The Watershed algorithm was applied to improve object separation. Objects >5000 pixels (i.e., clustered nuclei) were identified and reprocessed to improve separation. Since mRNA fluorescent puncta can be located in the endoplasmic reticulum, we dilated the boundaries of each segmented nucleus by five pixels to include these regions.
To segment fluorescent puncta, each of the three probe channels were first preprocessed using a Top-hat filter (9- to 15-pixel radius), Wiener filter (15 × 15 pixel neighborhood size) followed by contrast adjustment (saturating top and bottom 1% of intensities). Bright regions were segmented using the extended-maxima transform (8-connected neighborhood, 5 H-maxima). A Watershed algorithm followed by erosion was used to improve object separation. Objects less than five pixels were rejected as noise. The location of each punctum is defined as the centroid of the segmented object.
For each fluorescent probe image channel, we counted the number of segmented puncta lying within a nuclear boundary. To determine the puncta threshold for specific versus non-specific probe hybridization, we estimated the “baseline” number of puncta expected per nucleus by chance from non-specific hybridization. We first calculated the puncta count per pixel for all puncta lying outside of cell nuclei and then multiplied this value by the number of pixels for each DAPI-labeled nucleus. This background puncta count was assumed to follow a Poisson distribution, and we defined our threshold for categorizing a cell as “positive” for a given mRNA probe as the 95th percentile of this distribution. Consistency was calculated as the percentage of Drd1a+ (or Adora2a+, in the case of A2a-Cre) nuclei that are also positive for iCre. Specificity was calculated as the percentage of iCre+ nuclei that are also Drd1a+ (or Adora2a+). Off-target consistency and specificity were calculated the same way but substituting Drd1a+ (or Adora2a+) for each other in the above two equations.
Virus injection
Rats (n = 2 females, one from each line) were microinjected with 0.5 μl of AAV5-CAG-Flex-TdTomato virus (UNC Vector Core) in DS at three locations along a dorsal-ventral trajectory (AP: +1.5, ML: +2.2, DV: –3.0, –4.0, –5.0 from brain surface), and killed four weeks after surgery.
In vivo opto-tagging
Rats (n = 2, one male from each line) were injected with 1.0 μl of hSyn-Flex-ChrimsonR-TdTomato virus (UNC Vector Core) bilaterally in ventral striatum (AP: +1.75, ML: ±1.6, DV: –7.0 from brain surface) and implanted with two 64-channel drivable tetrode arrays, each with a fixed optical fiber extending centrally through the array to a depth of 6.5 mm. After three weeks of transfection, the tetrodes were lowered into the ventral striatum and recorded wideband (1–9000 Hz) at 30,000 samples/s using an Intan digital headstage. Recording ended with a brief laser stimulation protocol (1 mW, 638 nm, 1–10 ms/1 Hz). The rat was awake, unrestrained, and resting quietly throughout the recording.
Units were isolated offline using automated spike sorting software (MountainSort; Chung et al., 2017) followed by manual inspection. For a unit to be considered a successfully-identified Cre+ neuron it had to meet several criteria: (1) evoked spiking within 10 ms of laser onset, that reached the p < 0.001 significance level in the stimulus-associated latency test (Kvitsiani et al., 2013); (2) peak firing rate (z-scored) of >10 during both 5- and 10-ms laser pulses; (3) a Pearson correlation coefficient >0.9 between their average light-evoked wave form and their average session-wide wave form.
Imaging
Images were taken with a Nikon spinning disk confocal microscope with a 40× objective (Plan Apo Lambda NA 0.95). For viral tracing, images (2048 × 2048 pixels at 16-bit depth) were stitched in FIJI.
Behavior
Rats were maintained on a reverse light-dark schedule (12/12), testing was conducted during the dark phase, and rats were at least 70 d old at the start of the studies. Males and females were used for instrumental and Pavlovian studies. Males were used to evaluate cocaine-induced locomotor activity because of well-established sex differences in response to cocaine (Becker and Koob, 2016) and an insufficient available number of females to examine them separately.
For instrumental and Pavlovian procedures, procedures were conducted in operant chambers as described (Derman and Ferrario, 2018). Rats [D1-Cre–, n = 9 (three males, six females); D1-Cre+, n = 16 (seven males, nine females); A2a-Cre–, n = 8 (six males, two females); A2a-Cre+, n = 16 (10 males, six females)]. were food restricted to 85–90% of free-feeding body weight. For instrumental training, a food cup was flanked by two retractable levers. First, rats were given two sessions in which 20 food pellets (45 mg, Bioserv #F0021) were delivered into the food cup on a variable-interval schedule of 60 s (VI60). Next, rats underwent instrumental training in which responses on the “active” lever resulted in delivery of a single pellet (fixed ratio 1; FR1) and responses on the other ‘inactive’ lever had no consequences. Rats were trained to an acquisition criterion of 50 pellets within 40 min. The same rats then underwent Pavlovian conditioning using two auditory conditioned stimuli (CSs; tone and white noise, 2 min; four presentations of each CS per session, 5 min ITI, 12 sessions, 1 h/session). Fifteen seconds following CS+ onset, four pellets were delivered on a VI30 schedule. The CS– was presented an equal number of times, unpaired with pellets. Food cup entries were recorded in 10-s bins and entries during the first 10 s of CS presentations were used to evaluate conditioned anticipatory responding [i.e., before unconditioned stimulus (US) delivery].
Locomotor activity was assessed in a subset of the rats trained above (Cre–, n = 7; D1-Cre+, n = 7; A2a-Cre+, n = 7) using procedures similar to (Vollbrecht et al., 2016). Rats were allowed to feed freely for at least 5 d before locomotor testing. Testing was conducted in rectangular plastic chambers (25.4 × 48.26 × 20.32 cm) outfitted with photocell arrays around the base perimeter. Beam breaks were measured using CrossBreak software (Synaptech; University of Michigan). Rats were habituated to the testing chambers (30 min) and given two injections of saline (1 ml/kg, i.p.) separated by 45 min. Next, the acute locomotor response to cocaine was assessed. After a 30-min habituation, rats were given a saline injection followed 45 min later by cocaine (15 mg/kg, i.p.) and remained in the chambers for an additional 60 min. Locomotor activity was recorded in 5-min bins throughout and reported as crossovers (beam break at one end of the cage followed by beam break at the opposite end of the cage).
Results
Molecular design
The D1-Cre and A2a-Cre rat lines were designed so that the native Drd1a or Adora2a promoter drives expression of both the native receptor and the codon-improved Cre recombinase (iCre) sequence in a single transcription event (Fig. 1A). The use of iCre over Cre has been shown to enhance recombinase expression and limit epigenetic silencing in mammalian cells (Shimshek et al., 2002). For each line, a unique single strand guide RNA (sgRNA) was generated to induce double strand breaks at the terminus of the receptor coding sequence and microinjected into Long–Evans rat zygotes along with Cas9 and a circular plasmid containing the donor gene cassette. After correct recombination of the donor cassette, the 3’ end of target receptor sequence will be joined in frame with the “self-cleaving” peptide P2A (to separate the Cre protein after translation), followed by Cre with a nuclear localizing signal affixed at the amino terminus, and a peptide tag (HA for Adora2a, V5 for D1) to facilitate antibody-based detection.
Founder screening, germline transmission, and full genome sequencing
DNA samples from G0 potential founders were screened with primers to detect iCre in the genome (for primer sequences, see Materials and Methods). From this screen 21/96 potential D1-Cre, and 9/60 potential A2a-Cre founders were positive for iCre. Positive rats were then screened with additional primers across the junctions between native and introduced DNA stretches, to discriminate between correct and random genomic integration events (Fig. 1B). This yielded 7/21 correct D1-Cre insertions and 7/9 correct A2a-Cre insertions. The iCre insert was then completely sequenced in these rats (14 total) to confirm complete integration.
These G0 founders were mated with wild-type Long–Evans rats, and the G1 pups genotyped for iCre specific insertion as above to verify germline transmission. Colonies from one successful founder for each line were established and maintained by back-crossing to wild-type Long–Evans rats from commercial vendors (see Materials and Methods); all experimental results shown are from rats back-crossed for at least three generations.
After five generations of back-crossing, we took one female rat each from the D1-Cre and A2a-Cre lines and sequenced their entire genomes to confirm that iCre was present in the intended location and nowhere else (Fig. 1C). Average sequencing depths for D1-Cre and A2a-Cre lines were 80× (1,503,983,138 reads) and 71× (1,358,732,834 reads), respectively. To determine the location of the inserted gene cassette, we identified paired sequence reads for which one mate of the pair aligned to the rat genome (Rnor_6.0) and the other mate aligned to the inserted gene cassette. All such reads were aligned to the genome in the expected location in each line (24/24 D1-Cre, 25/25 A2a-Cre), indicating correct, single copy insertion (Fig. 1C).
Partial sequence matches between the sgRNA and genomic locations away from the intended target may induce “off-target” cleavage events. Any off-target changes are likely to be progressively diluted over successive generations of back-crossing. We nonetheless performed an extensive screen and found no evidence for off-target events (see Materials and Methods).
Consistent and specific Cre expression in Drda1-expressing or Adora2a-expressing cells
The knock-in design ought to produce iCre mRNA expression that is highly faithful to the natural distribution of Drd1a (or Adora2a) mRNA. To assess this, we used triple fluorescent in situ hybridization, together with DAPI labeling of cell nuclei. Probe sets targeting iCre, Adora2a receptor and Drd1a receptor mRNA with distinct color labels were multiplexed and visualized simultaneously (Fig. 2A). mRNA expression was quantified in three distinct striatal subregions, the DS, the nucleus accumbens core, and the nucleus accumbens medial shell. Automated software was used to define cell boundaries and count fluorescent puncta per cell, for each probe (Fig. 2A).
Relationships between puncta counts for Drd1a, Adora2a, and iCre are shown in Figure 2B, left column, D1-Cre, and right column, A2a-Cre. As expected, in D1-Cre rats expression of Drd1a and iCre mRNA was closely correlated in all striatal subregions examined (DS: R 2 = 0.80; core: R 2 = 0.70; shell: R 2 = 0.70; Fig. 2B), and there was no correlation between Adora2a and iCre mRNA (DS: R 2 = 0.008; core: R 2 = 0.035; shell: R 2 = 0.027). Conversely, in A2a-Cre rats expression of Adora2a and iCre mRNA was closely correlated (DS: R 2 = 0.89; core: R 2 = 0.79; shell: R 2 = 0.86), and there was no correlation between Drd1a and iCre mRNA (DS: R 2 = 0.019; core: R 2 = 0.001; shell: R 2 = 0.034). Consistent with earlier in situ hybridization studies (Le Moine and Bloch, 1995; Berke et al., 1998), we found near-complete segregation of dMSN and iMSN markers in all regions examined, with virtually no overlap between Drd1a and Adora2a expression (Fig. 2A,B).
To further assess the specificity and consistency of iCre mRNA expression we defined thresholds for considering neurons as positive for a given probe. Given the wide distributions of puncta counts, the choice of threshold is non-trivial; it forces a trade-off between Type I and Type II errors. Therefore, rather than picking an arbitrary threshold, for each probe we chose the 95% upper confidence limit, assuming a Poisson background distribution of puncta (see Materials and Methods). Using these thresholds (marked by red lines on the Fig. 2B, scatterplots) we estimated A2a-Cre specificity (% of iCre+ that are also Adora2a+) to be 93.5% (DS), 91.8% (core), and 89.2% (shell), and consistency (% of Adora2a+ that are also iCre+) to be 82.8% (DS), 77.4% (core), and 86.2% (shell). In the D1-Cre line, we estimated specificity (% of iCre+ that are also Drd1a+) to be 89.1% (DS), 87.4% (core), and 81.8% (shell), and consistency (% of Drd1a+ that are also iCre+) to be 77.5% (DS), 70.1% (core), and 74.6% (shell). If we use even higher thresholds for Drd1a and Adora2a (e.g., >30 puncta/cell), we can be essentially certain of cell identity and assessed this way consistency was close to 100% for both lines (Fig. 2B).
Cre-dependent protein expression
We next examined whether iCre mRNA expression results in functional Cre protein confined to the appropriate basal ganglia pathway. To this end, we injected DS with a virus for Cre-dependent expression of a fluorescent protein (AAV-CAG-FLEX-tdTomato) and examined the expression pattern four weeks later. Consistent with pathway-specific expression of functional Cre protein, injection into the D1-Cre line resulted in clear expression in the striato-nigral pathway, while injection into the A2a-Cre line produced labeling in both DS and GPe, but no expression in the SNr (Fig. 3A).
One important use of Cre lines is to enable positive identification of recorded neuron subtypes in awake behaving animals (Kravitz et al., 2010), via Cre-dependent opsin expression and monitoring neuronal responses to light pulses. We found that both the D1-Cre and A2a-Cre rat lines can be used for this purpose. In rats from each line we injected a virus (AAV-hSyn-FLEX-ChrimsonR-Tdtomato) into the accumbens core for Cre-dependent expression of the red-shifted opsin Chrimson (Klapoetke et al., 2014; Fig. 3B, left) followed by a custom optrode (Mohebi et al., 2019). After allowing three weeks for opsin expression, we readily observed light-responsive single units (Fig. 3B, middle). In a representative example session from a D1-Cre rat 17 neurons were identified as dMSNs, as they showed both a reliable response to red light stimulation and the wave form properties typical of MSNs (Fig. 3B, right; Berke et al., 2004; Gage et al., 2010). As these cells were intermingled within the larger MSNs cluster, it would not have been possible to identify them without this optogenetic tagging procedure.
Normal acquisition and performance of instrumental and Pavlovian discrimination and cocaine-induced locomotor activity
Given that behavioral comparisons are likely to be made across these two independent transgenic lines, and between Cre+ rats and Cre– controls, we assessed acquisition and expression of instrumental responding for food and Pavlovian conditioned approach, and cocaine-induced locomotor activity in these lines.
In the instrumental discrimination task presses on an active lever were reinforced with food pellet delivery (fixed ratio of 1; FR1), whereas presses on an inactive lever were never reinforced. Rats were trained to an acquisition criterion of earning 50 pellets within <40 min. Figure 4A shows the average number of active and inactive lever responses, and Figure 4B depicts the average time to reach the acquisition criterion in each group. As expected active lever responding was greater than inactive lever responding, and this did not differ between groups (two-way repeated-measures ANOVA, main effect of lever: F(1,90) = 193.2, p < 0.0001; n.s. main effect of group: F(3,90) = 1.379, p = 0.2545; n.s. group × lever interaction: F(3,90) = 0.408, p = 0.747). The time to reach acquisition criterion did not differ between groups (two-way repeated-measures ANOVA, n.s. main effect of lineage: F(1,45) = 2.593, p = 0.1143; n.s. main effect of genotype: F(1,45) = 1.578, p = 0.2155; n.s. lineage × genotype interaction: F(1,45) = 0.1086, p = 0.7433).
Following instrumental training, the acquisition and expression of Pavlovian conditioned approach were assessed in the same rats. During each session, one auditory cue was paired with food pellet delivery (CS: CS+), whereas a second auditory cue was never paired with food (CS–). Rats received 12 training sessions (60 min) in which each CS (tone or white noise, counterbalanced for CS+/CS– assignment) was randomly presented four times per session. Acquisition of Pavlovian conditioned food cup approach was similar across transgenic lines and between Cre– and Cre+ groups. Specifically, Figure 4C,D shows the average number of food cup entries during the first 10 s of CS+ and CS– in two-session blocks, respectively. Anticipatory food cup entries during CS+ presentations increased across training blocks and did not differ between groups (two-way repeated-measures ANOVA, main effect of training block: F(5,225) = 13.45, p < 0.0001; n.s. main effect of group: F(3,45) = 0.505, p = 0.6807; n.s. group × training block interaction: F(15,225) = 0.6086, p = 0.866; Fig. 4C). In contrast, food cup entries during the first 10 s of CS– presentations did not increase across sessions and was similar across groups (two-way repeated-measures ANOVA, n.s. main effect of training block: F(5,225) = 1.602, p = 0.1606; n.s. main effect of group: F(3,45) = 0.01628, p = 0.9971; n.s. group × training block interaction: F(15,225) = 1.476, p = 0.1155; Fig. 4D). Thus, acquisition and maintenance of discriminatory conditioned approach were similar across transgenic lines, and between Cre– and Cre+ groups.
To provide an additional measure of learning we also examined the latency to enter the food cup following CS presentations. The average latency to enter the food cup following the onset of the CS+ decreased across training blocks and this decrease did not differ between groups, demonstrating that all groups were similarly motivated to respond to reward-predictive cues (two-way repeated-measures ANOVA, main effect of training block: F(5,225) = 16.95, p < 0.0001; n.s. main effect of group: F(3,45) = 1.239, p = 0.307; n.s. group × training block interaction: F(15,225) = 0.3964, p = 0.9791; Fig. 4E). In contrast, the average latency to enter the food cup following the onset of the CS– increased across training blocks, and did not differ between groups (two-way repeated-measures ANOVA, main effect of training block: F(5,225) = 12.38, p < 0.0001; n.s. main effect of group: F(3,45) = 0.6639, p = 0.578; n.s. group × training block interaction: F(15,225) = 0.4812, p = 0.9485; Fig. 4F). Together, the results from these behavioral studies show that introduction of Cre into either D1- or A2a neurons does not disrupt normal acquisition or expression of instrumental and Pavlovian discriminations.
Locomotor habituation and cocaine-induced locomotor activity were used to assess general striatal function in both lines (Oginsky et al., 2016). Cre+ rats and their Cre– littermates were placed in standard locomotor chambers equipped with photocell beams around the perimeter. After a 30-min habituation period, they were given two intraperitoneal injections of saline (1 ml/kg). Both lines showed typical habituation to the locomotor chambers, and short-lived responses to saline injection that decreased with repeated injection (two-way repeated-measures ANOVA, main effect of time: F(21,378) = 10.42, p < 0.0001; Fig. 5A). Locomotor activity was similar across D1-Cre and A2a-Cre lines and between Cre+ and Cre– rats (two-way repeated-measures ANOVA, n.s. effect of genotype: F(2,18) = 0.3965, p = 0.6784; Fig. 5A). The next day, rats were again placed in locomotor chambers and given an injection of saline followed 40 min later by cocaine (15 mg/kg, i.p.). As expected, cocaine significantly increased locomotor activity, and the magnitude and time course of this response was similar between Cre+ and Cre– rats, as well as across transgenic lines [two-way repeated-measures ANOVA, main effect of time: F(23,414) = 6.901, p < 0.0001; n.s. effect of genotype: F(2,18) = 0.09284, p = 0.9118 (Fig. 5B); two-way repeated-measures ANOVA, main effect of injection: F(1,18) = 10.51, p = 0.0045; n.s. effect of genotype: F(2,18) = 0.1284, p = 0.8803; n.s. injection by genotype interaction: F(2,18) = 0.1122, p = 0.8945 (Fig. 5C)]. Thus, all genotypes showed a significant increase in locomotor activity following cocaine versus saline injection, and this effect did not differ between genotypes. These data suggest that there is no overt striatal dysfunction due to Cre expression, and that behavioral responses to elevations in dopamine are similar across D1-Cre and A2a-Cre lines.
Discussion
We have demonstrated successfully targeted, functional knock-in of Cre recombinase at the Drd1a and Adora2a loci, without off-target insertions as assessed by multiple methods including whole-genome sequencing. Comparable behavioral performance across lines and between Cre+ and Cre– littermates in several basic behavioral procedures provides further confidence that there are no unexpected deleterious effects of genetic manipulation or co-production of Cre recombinase with endogenous receptors. Within striatum we showed that Cre expression was consistent and selective to the correct populations of direct pathway D1+ and indirect pathway A2a+ cells, respectively. Thus, these D1-Cre and A2a-Cre transgenic rats enable selective monitoring or manipulation of dMSNs and iMSNs with high specificity. Although we fully expect Cre to be correctly targeted in other brain regions too, further characterization will be required to confirm this.
D1-Cre and A2a-Cre transgenic rats offer clear advantages over currently available transgenic models. First, the greater capacity of rats to learn complex behaviors make them stronger candidates for a wider range of tasks compared to mice. Second, the increased carrying capacity afforded by rats facilitates the chronic implantation of larger devices (i.e., high channel-count headstages, graded-refractive-index lenses). Thirdly, knock-ins can be used with higher confidence that the genetic modification was selective and specific to the target, compared to BAC lines.
A long-standing question in basal ganglia research has been the degree to which the striatal MSNs population can be fully divided into distinct D1+ and D2+/A2a+ subpopulations. Based on BAC transgenic mice overlap has been reported to range from 4% to 5% in DS and nucleus accumbens core, and up to 17% in shell (Bertran-Gonzalez et al., 2008; Wei et al., 2018). Our quantification of Drd1 and Adora2a mRNA expression found overlap to be consistently very low in all striatal subregions examined, including shell, providing additional evidence for a fundamentally segregated striatal architecture.
Since Cre expression was highly specific to the intended striatal pathways, these rats are powerful tools for pathway-specific neuron identification and manipulations. One caveat is that a subset of fast-spiking, parvalbumin-positive (PV+) interneurons also express D1 receptors (Bracci et al., 2002), and may thus also express Cre in D1-Cre rats. However, PV+ are only ∼0.7% of striatal neurons (Luk and Sadikot, 2001) and at least in electrophysiological studies can be readily differentiated from MSNs (Kawaguchi, 1993; Koós and Tepper, 1999; Berke, 2008).
We chose to examine behavior during simple instrumental and Pavlovian tasks as well as cocaine-induced locomotor activity, as these behaviors rely heavily on striatal function. Although behavioral differences might emerge under other, more complex task conditions, the lack of any overt differences between the D1-Cre and A2a-Cre transgenic lines, or between Cre– and Cre+ littermates, strongly suggest that these rats are well-suited for behavioral and systems neuroscience studies. Beyond striatum, A2a receptors are found in the cortex, globus pallidus, hippocampus, thalamus, cerebellum (Rosin et al., 1998), and throughout the cardiovascular system. Similarly, D1 receptors are located in prefrontal cortex, hippocampus, thalamus, and hypothalamus (Fremeau et al., 1991). In coordination with a rapidly expanding set of optical and genetic tools, these rats increase our ability to address fundamental questions about brain circuitry and mechanisms underlying neurologic and psychiatric disorders.
Acknowledgments
Acknowledgements: We thank E. Wan and D. Vaka from the University of California, San Francisco Institute for Human Genomics Core for performing the whole genome sequencing and assembly, H. Graham for assistance with FISH quantification, and R. Hashim, H. Bukhari, M. Zeidler, F. Ayres, Y. Alonso Caraballo, and F. Sanchez Conde for assistance with breeding and genotyping. The rat lines have been deposited with the Rat Resource and Research Center (rrrc.us) for community distribution (D1-Cre: RRRC#856, A2a-Cre: RRRC#857), and we thank E. Bryda for her help with this process.
Footnotes
The authors declare no competing financial interests.
This work was supported by National Institute on Drug Abuse (NIDA) Awards R01DA045783 (to J.D.B.), R21DA045277 (to C.R.F.), and T32DA007281 (to R.C.D.); the National Institute on Neurological Disorders and Stroke Award R01NS078435 (to J.D.B.); the National Institute of Mental Health Award R01MH101697 (to J.D.B.); National Institute of Diabetes and Digestive and Kidney Diseases Awards R01DK106188 (to C.R.F.), R01DK115526 (to C.R.F.), and F31DK111194 (to R.C.D.); the CHDI Foundation (J.D.B.); the University of Michigan; and the University of California, San Francisco. Support for the Transgenic Animal Model Core of the University of Michigan’s Biomedical Research Core Facilities was provided by The University of Michigan Cancer Center [National Institutes of Health (NIH) Award P30CA46592], the University of Michigan Gut Peptide Research Center (NIH Award P30DK34933), and the University of Michigan George M. O'Brien Renal Core Center (NIH Award P30DK08194). Cocaine was provided by the NIDA drug supply program.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.